- for
medical use in the
United States in
October 2010, and is
marketed by
Avanir Pharmaceuticals. DXM/quinidine is used in the
treatment of PBA. In a 12-w****...
-
Pharmaceuticals (Merged 2011, Acq 2013)
Astex Therapeutics Limited SuperGen, Inc
Avanir Pharmaceuticals (Acq 2014)
Daiya (Acq 2017)
ReCor Medical, Inc. (Acq 2019)...
-
nasal spray form of
sumatriptan known as AVP-825 has been
developed by
Avanir and is
generically available in some countries.
According to the American...
-
dextromethorphan (DXM)) and
quinidine (Q)
which is
under development by
Avanir Pharmaceuticals for the
treatment of a
variety of
neurological and psychiatric...
-
March 2007, it was the
subject of a US
nationwide class-action suit
against Avanir and
GlaxoSmithKline as the
claim that it cut
recovery times in half was...
-
original on 2006-09-24.
Retrieved 2006-09-05. "
Avanir's press release: FDA
approves Onzetra".
Avanir Pharmaceuticals.
January 28, 2016.
Archived from...
- dəbu] [syɾ lə sɔle syɾ lõdə] [o sõde ta-tɑ̃] [dɑ̃ lœɾ ɾitmə gɾɑ̃disɑ̃] [ɾɛstõz‿ yni tuʒuɾ] [e kə ʃakœ̃ ɾepõdə] [a sə nɔbl
avəniɾ] [ki nu dit:ɑ̃n‿ avɑ̃]...
-
Takeda and
Sanofi Aventis, with
biotechnology customers including Amgen and
Avanir Pharmaceuticals. As of 2016,
Patheon had
manufactured or
developed more...
- Squarex, LLC Hugh McTavish, PhD, JD
Topical immunological adjuvant Phase II
Docosanol GlaxoSmithKline,
Avanir ?
Topical cell
entry inhibitor In Production...
- adisinsight.springer.com.
Retrieved February 19, 2023. "Deudextromethorphan -
Avanir Pharmaceuticals - AdisInsight". adisinsight.springer.com. Springer. Retrieved...
